Journal
ONCOTARGET
Volume 7, Issue 31, Pages 50150-50160Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.10322
Keywords
patient-derived tumor xenograft; lymphomagenesis; Epstein-Barr virus; colorectal cancer; BamHI W region
Categories
Funding
- Japan Society of the Promotion of Science
- Japan Foundation for Applied Enzymology
- Itoh-Chubei Foundation
- Grants-in-Aid for Scientific Research [15K14381, 26460932] Funding Source: KAKEN
Ask authors/readers for more resources
Establishment of patient-derived tumor xenografts (PDXs) is hampered by lymphomagenesis mostly caused by the latently-infected Epstein-Barr virus (EBV) contained in patient cancer tissues. However, the character of patient tissues that result in lymphomagenesis after xenotransplantation is not elucidated. In this study, we analyzed the patient colorectal cancer (CRC) tissues and the PDXs established by their xenotransplantation. We found that 2 of 9 (22%) PDX tumors were EBV-associated human diffuse large B cell lymphoma which was formed by clonal proliferation of human B-cell lymphocytes, were strongly positive for EBER-ISH, and were classified as type III latency. Expression of EBV genes and RNAs, such as EBNAs, LMP1, EBER and EBV-associated microRNAs in patient CRC tissues were unlikely to be associated with lymphomagenesis in PDXs. In contrast, the positive PCR-based amplification of BamHI W region, a major internal repeat in EBV genome, in the patient CRC tissues was correlated with lymphomagenesis in PDXs. These results suggest that the detection of the EBV BamHI W region in the patient surgical specimens will be an effective way to predict the risk of lymphomagenesis in PDXs before xenotransplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available